Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

996
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
996
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.5K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

3.2K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
3.2K
Ligand Binding Sites02:40

Ligand Binding Sites

13.1K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
13.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Towards time-resolved MicroED grid preparation using mix-and-inject gas dynamic virtual nozzles.

IUCrJ·2026
Same author

Structure and enzymology of glutaminase S482C and H461L variants associated with excess brain glutamate and neurological disease.

The Journal of biological chemistry·2026
Same author

A highly dynamic active state for transducin-bound phosphodiesterase-6 in vertebrate phototransduction.

bioRxiv : the preprint server for biology·2026
Same author

Nucleotide-Specific RNA Conformations and Dynamics as Precursors to Ribonucleoprotein Condensates.

Journal of the American Chemical Society·2025
Same author

Structure and enzymology of glutaminase mutants that disrupt glutamine-glutamate homeostasis and cause neurological disease.

bioRxiv : the preprint server for biology·2025
Same author

Revealing Functional Hotspots: Temperature-Dependent Crystallography of K-RAS Highlights Allosteric and Druggable Sites.

bioRxiv : the preprint server for biology·2025
Same journal

Predicting Nirmatrelvir Resistance in SARS-CoV-2 M<sup>pro</sup> Mutants with an Integrated Computational Framework.

The journal of physical chemistry. B·2026
Same journal

From Cation Solvation to Anion Coordination: Lewis-Acidic Boranes Enable Halide Salt Electrolytes.

The journal of physical chemistry. B·2026
Same journal

In Vitro-Prepared A30P Alpha-Synuclein Fibrils Adopt the Conserved and Disease-Relevant Greek Key Fold.

The journal of physical chemistry. B·2026
Same journal

Metastructure Analysis of Self-Assembled Nanocubes with Different Equatorial Methyl Groups Based on Molecular Dynamics Simulations.

The journal of physical chemistry. B·2026
Same journal

A Cocoordinated <sup>1</sup>H Internal Reference Quantifies Proton-Exchange Bias in Coordinated-Water Diffusion.

The journal of physical chemistry. B·2026
Same journal

Unveiling Electrolyte-Dependent Coordination Site Dynamics for Redox Mediator Design in Lithium-O<sub>2</sub> Batteries: Exchange vs Rearrangement.

The journal of physical chemistry. B·2026
See all related articles

Related Experiment Video

Updated: Aug 30, 2025

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.0K

Evolving Experimental Techniques for Structure-Based Drug Design.

Cody Aplin1, Shawn K Milano1, Kara A Zielinski2

  • 1Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, United States.

The Journal of Physical Chemistry. B
|August 27, 2022
PubMed
Summary
This summary is machine-generated.

New structural techniques offer dynamic insights into protein targets for drug discovery. Advances in X-ray crystallography, cryo-electron microscopy (cryoEM), and small-angle X-ray scattering (SAXS) aid rational drug development.

More Related Videos

Modeling an Enzyme Active Site using Molecular Visualization Freeware
14:37

Modeling an Enzyme Active Site using Molecular Visualization Freeware

Published on: December 25, 2021

10.1K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.4K

Related Experiment Videos

Last Updated: Aug 30, 2025

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.0K
Modeling an Enzyme Active Site using Molecular Visualization Freeware
14:37

Modeling an Enzyme Active Site using Molecular Visualization Freeware

Published on: December 25, 2021

10.1K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.4K

Area of Science:

  • Structural Biology
  • Drug Discovery
  • Biophysics

Background:

  • Structure-based drug design (SBDD) traditionally relies on static, cryogenic protein models.
  • Understanding protein dynamics is crucial for effective rational drug development.
  • Existing methods often lack the ability to capture dynamic conformational information.

Purpose of the Study:

  • To highlight recent advancements in structural techniques for probing protein dynamics.
  • To discuss the application of these techniques in structure-based drug design.
  • To explore novel methods for studying protein-inhibitor interactions and complexes.

Main Methods:

  • Serial room-temperature crystallography for high-resolution conformational dynamics.
  • Cryogenic electron microscopy (cryoEM) for challenging protein targets.
  • Small-angle X-ray scattering (SAXS) for high-throughput screening of complexes.

Main Results:

  • Serial room-temperature crystallography provides detailed conformational dynamics of protein-inhibitor complexes.
  • CryoEM enables high-resolution structural studies of previously intractable proteins and complexes.
  • SAXS demonstrates potential as a high-throughput tool for identifying inhibitors of protein complexes.

Conclusions:

  • Advancements in structural biology techniques offer powerful new avenues for drug discovery.
  • Probing protein dynamics is essential for developing more effective therapeutics.
  • These techniques enhance the capabilities of structure-based drug design.